JDRF Blog

There are 3 item(s) tagged with the keyword "BD".

1. JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes

JDRF and BD (Becton, Dickinson and Company) (NYSE:BDX) are accelerating the development of new products that combine BD’s proprietary insulin infusion and glucose sensing technologies through a new collaboration announced today.


2. JDRF Launches Research Program to Accelerate Delivery of Faster Acting Insulin; Key Step on Road to an Artificial Pancreas

NEW YORK, August 16, 2010 - JDRF announced today another important step on the road to the development of an artificial pancreas - an automated system to better manage the blood sugar of people with type 1 diabetes - with the establishment of a research program to speed the development of faster-act...


3. JDRF and BD Collaborate to Improve Insulin Pump Delivery

New York, NY and Franklin Lakes, NJ (January 19, 2010) - The Juvenile Diabetes Research Foundation (JDRF) and BD (Becton, Dickinson and Company) (NYSE:BDX) announced today an innovative program aimed at improving the treatment of type 1 diabetes by developing novel insulin delivery products to enhan...


Lets turn type one into type none